Rahul Bohra: Beyond Platelet Counts – The Lived Experience of ITP
Rahul Bohra, Global Medical Lead/Sr. Director, Launch and Pipeline Assets in Rare Diseases at Sanofi, shared American Society of Hematology‘s post on LinkedIn:
” ‘Windchill Factor’ The gap between measured disease and lived experience.
In a disease like ITP (Immune Thrombocytopenia), fatigue captures something numbers alone can miss: what the disease actually feels like to the person living with it.
In this HemeTalks episode, ITP warrior and advocate Barbara Pruitt who has over 60 years of lived experience, shares a wealth of information from diagnosis trauma, the journey, snorkeling and support resources like PDSA.
American Society of Hematology shared a post on LinkedIn:
“Quality of life matters as much as lab values.
On the latest HemeTalks, patient advocate Barbara Pruitt shares her experience living with immune thrombocytopenia (ITP) and reminds hematologists to look beyond platelet counts to the whole patient.
From childhood steroids and a splenectomy to newer therapies today, Ms. Pruitt reflects on more than six decades of treatment, the everyday adjustments that help her keep traveling and dancing, and the power of finding community through a patient organization.
Don’t miss this important discussion with hosts Ronak Mistry and Vivek Patel.
Thank you to Sanofi for supporting this episode!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 13:34Yohei Hisada: How Well Do Mouse Leukemia Models Reflect Human Disease?
-
Nov 20, 2026, 13:20Ilenia Calcaterra: The Inferior Thyroid Arteries as a Window Into Cardiovascular Risk
-
Nov 20, 2026, 13:03Does Being Fit Protect Against VTE? – RPTH Journal
-
Nov 20, 2026, 12:29Thirunavukkarasu Angappan: Antithrombin in ECMO – Two Datasets, Two Opposite Answers
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance
-
Nov 20, 2026, 11:33Tyler McConville: Why Hemostatic Function Matters More Than Cell Counts in Trauma and Transfusion
-
Nov 20, 2026, 11:28Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients
-
Nov 20, 2026, 11:19EHC Urges Equal Early Diagnosis for Bleeding Disorders
-
Nov 20, 2026, 11:14Pushpinder Singh: How Do We Know if Haemodialysis is Effective?